Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
Ital J Pediatr ; 47(1): 35, 2021 Feb 17.
Article in English | MEDLINE | ID: mdl-33596989

ABSTRACT

BACKGROUND: Indirect hyperbilirubinemia is frequently encountered during neonatal period. Although it has different causes, in some cases it can't be explained. Previous studies have illustrated that jaundice could be a major sign of urinary tract infection (UTI) in neonates. AIM OF THE WORK: We aimed to determine the association between UTI and significant unexplained neonatal indirect hyperbilirubinemia. METHODS: This prospective controlled study was performed on 150 neonates divided in two groups (100 as cases and 50 as controls) to investigate the incidence of UTI in neonates with significant unexplained hyperbilirubinemia. Urine sample was obtained using urine catheterization technique from neonates and full urine analysis was done and cases with pyuria had urine culture to confirm UTI. Immediate renal ultrasonography (USG) was performed for neonates with UTI. RESULTS: UTI incidence was 11% in cases while none of neonates in control group had UTI with statistical significance between cases and controls (P value < 0.05). The most common (36.4%) pathogen was Escherichia coli. Posterior urethral valve with mild hydronephrosis was diagnosed in 18.2% of UTI positive patients by renal ultrasonography. CONCLUSION: In neonates with unexplained indirect hyperbilirubinemia, UTI should be considered as a pathological cause.


Subject(s)
Hyperbilirubinemia, Neonatal/complications , Urinary Tract Infections/epidemiology , Bacteria/isolation & purification , Case-Control Studies , Egypt/epidemiology , Female , Humans , Hyperbilirubinemia, Neonatal/urine , Incidence , Infant, Newborn , Male , Prospective Studies , Urinalysis , Urinary Tract Infections/etiology , Urinary Tract Infections/microbiology , Urine/microbiology
2.
Dis Markers ; 2014: 315843, 2014.
Article in English | MEDLINE | ID: mdl-25049438

ABSTRACT

PURPOSE: To investigate renal function estimated by markers in full-term newborns with hyperbilirubinemia. METHODS: A total of 332 full-term newborns with hyperbilirubinemia and 60 healthy full-term newborns were enrolled. Total serum bilirubin, serum creatinine (Cr), serum blood urea nitrogen (BUN), serum cystatin C (Cys-C), urinary beta-2-microglobulin (ß 2MG) index, and urinary N-acetyl-beta-D-glucosaminidase (NAG) index were measured before and after treatment. All newborns were divided into three groups according to total serum bilirubin levels: group 1 (221-256), group 2 (256-342), and group 3 (>342). RESULTS: The control group and group 1 did not differ significantly in regard to serum Cr, serum BUN, serum Cys-C, urinary ß 2MG index, and urinary NAG index. Urinary NAG index in group 2 was significantly higher than that in control group (P < 0.001). Between control group and group 3, serum Cys-C, urinary ß 2MG index, and urinary NAG index differed significantly. The significant positive correlation between total serum bilirubin and urinary NAG index was found in newborns when total serum bilirubin level was more than 272 µmol/L. CONCLUSIONS: High unconjugated bilirubin could result in acute kidney injury in full-term newborns. Urinary NAG might be the suitable marker for predicting acute kidney injury in full-term newborns with hyperbilirubinemia.


Subject(s)
Acetylglucosaminidase/urine , Acute Kidney Injury/urine , Hyperbilirubinemia, Neonatal/urine , Acute Kidney Injury/diagnosis , Biomarkers/urine , Case-Control Studies , Female , Humans , Infant, Newborn , Male
3.
Neuro Endocrinol Lett ; 30 Suppl 1: 29-31, 2009.
Article in English | MEDLINE | ID: mdl-20027140

ABSTRACT

OBJECTIVES: To present clinical and laboratory findings in the case of a term newborn with conjugated hyperbilirubinaemia and to stress the importance of differential diagnosis. RESULTS: A term newborn delivered by caesarean section (birth weight 2550 g, birth length 47 cm, value of Apgar score 9/10) with good direct adaptation had on the first day of life increased levels of conjugated bilirubin (23 micromol/l), unconjugated bilirubin (55 micromol/l) and C-reactive protein 39.4 g/l. The diagnosis of mevalonic aciduria was confirmed by urine analysis (mevalonolactone 393 micromol/mmol crea, normal range <2.0 micromol/mmol crea; mevalonic acid 40.5 micromol/mmol crea, normal range <0.04 micromol/mmol crea). CONCLUSION: Mevalonic aciduria can be clinically distinguished based on symptoms of neurological involvement. It can also present itself with hepatosplenomegaly, lymphadenopathy, anaemia, leukocytosis, increased sedimentation rates and levels of C-reactive protein. In cases of conjugated hyperbilirubinaemia of unknown aetiology it is important to exclude mevalonic aciduria by urine investigation for organic acids.


Subject(s)
Hyperbilirubinemia, Neonatal/diagnosis , Hyperbilirubinemia, Neonatal/urine , Mevalonate Kinase Deficiency/diagnosis , Mevalonate Kinase Deficiency/urine , Diagnosis, Differential , Humans , Hyperbilirubinemia, Neonatal/etiology , Infant, Newborn , Male , Mevalonate Kinase Deficiency/complications
SELECTION OF CITATIONS
SEARCH DETAIL
...